Evidence map›Paper›PMID 21291532›Full record

ArticleWorld journal of surgical oncology2011

A case report of male breast cancer in a very young patient: what is changing?

Marcelo Madeira, André Mattar, Rodrigo José Barata Passos, Caroline Dornelles Mora, Luiz Henrique Beralde Vilar Mamede, Viviane Hatsumi Kishino, Thomas Zurga Markus Torres, Andressa Fernandes Rodrigues de Sá, Roberto Euzébio dos Santos, Luiz Henrique Gebrim

Abstract readCase Reports
In one paragraph

Article in World journal of surgical oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Nanoparticle-mediated targeted drug delivery for breast cancer treatment.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  4. Debunk the myths: oncologic misconceptions.The Indian journal of medical research · 2014
    Article
  5. Invasive ductal breast carcinoma underneath a lipoma in a male patient.The Journal of clinical and aesthetic dermatology · 2012
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marcelo MadeiraSenology Discipline, São Paulo Federal University, São Paulo, Brazil. marcemadeira@gmail.com
André Mattar
Rodrigo José Barata Passos
Caroline Dornelles Mora
Luiz Henrique Beralde Vilar Mamede
Viviane Hatsumi Kishino
Thomas Zurga Markus Torres
Andressa Fernandes Rodrigues de Sá
Roberto Euzébio dos Santos
Luiz Henrique Gebrim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Male breast cancer accounts for 1% of all breast cancer cases, and men tend to be diagnosed at an older age than women (mean age is about 67 years). Several risk factors have been identified, such as genetic and hormonal abnormalities. The present study reported the case of a 25-year-old man who was diagnosed with an advanced invasive ductal carcinoma; however, he did not have any important risk factors. Even though more data is emerging about this disease, more efforts to understand risk factors, treatment options and survival benefits are needed. In this case, we discussed the risk factors as well as the impaired fertility associated with breast cancer therapies.

Indexed as

AdultBreast Neoplasms, MaleCarcinoma, Ductal, BreastCombined Modality TherapyFatal OutcomeFertilityHumansMaleMammographyRisk Factors

Identifiers

PMID21291532
PMCPMC3039618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.